(Q46639944)

English

The superiority of allogeneic hematopoietic stem cell transplantation from unrelated donor over chemotherapy for adult patients with high-risk acute lymphoblastic leukemia in first remission

scientific article published in November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

The superiority of allogeneic hematopoietic stem cell transplantation from unrelated donor over chemotherapy for adult patients with high-risk acute lymphoblastic leukemia in first remission (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Ling Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

Ying Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

Wei Tang

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

Han-Bo Dou

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

Jie-Hui Shan

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

Jiong Hu

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

publication date

1 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

98

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

569-577

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

Treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Rese

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Which patients with adult acute lymphoblastic leukemia should undergo a hematopoietic stem cell transplantation? Case-based discussion

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1442-5

21 January 2018

The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties

1 reference

https://pubmed.ncbi.nlm.nih.gov/24078372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24078372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New approaches to acute lymphoblastic leukemia in adults: where do we go?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24078372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24078372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24078372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/24078372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24078372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the F

1 reference

https://pubmed.ncbi.nlm.nih.gov/24078372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24078372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic Stem Cell Transplantation in First Complete Remission Enhances Graft-versus-Leukemia Effect in Adults with Acute Lymphoblastic Leukemia: Antileukemic Activity of Chronic Graft-versus-Host Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24078372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-013-1442-5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24078372

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46639944&oldid=2207995583"